Discovering drugs: “Blue skies research is essential. That is where the biggest value is.  You have to fund research here because you never know: we might crack it.”

For decades now, successive governments have courted big pharma and encouraged them to set up in Ireland and manufacture their drugs. This has created(...)

Prof Luke O’Neill: “I won’t be quitting the immune system any time soon.” Photograph: Nick Bradshaw

Prof Luke O’Neill is happy. This is not unusual: the biochemistry professor is known for his ebullience. But there’s an extra dimension to the good h(...)

Trinity College Dublin. Photograph: Bryan O’Brien

Trinity College Dublin and UCD have put their rivalry aside to collaborate on a new €60 million investment fund for high-potential start-ups. Speci(...)

A globally recognised centre of excellence in medical technology, or medtech, Ireland is home to more than 300 companies, employing 25,000 people. (...)

Opsona Therapeutics, a biopharma company spun out of Trinity College (above), is developing drugs designed to block a protein  in the body that works to reject foreign organisms. Photograph: Dara Mac Donaill

Opsona Therapeutics, a biopharma company spun out of Trinity College, has embarked on a series of trials to see if its leading therapy could prove ef(...)

Irish companies raised €285 million from venture capital investors last year, according to new data from the Irish Venture Capital As(...)

Irish biopharma company Opsona Therapeutics last week announced a new round of investment, to the tune of €33 million. Their goal? To dampen th(...)